Human Papilloma Virus Clinical Trials

33 recruitingLast updated: June 17, 2026

There are 33 actively recruiting human papilloma virus clinical trials across 14 countries. Studies span Not Applicable, Phase 2, Phase 3, Phase 1, Phase 4, Early Phase 1. Top locations include Plainfield, Indiana, United States, San Antonio, Texas, United States, Montreal, Quebec, Canada. Updated daily from ClinicalTrials.gov.


Human Papilloma Virus Trials at a Glance

33 actively recruiting trials for human papilloma virus are listed on ClinicalTrialsFinder across 6 cities in 14 countries. The largest study group is Not Applicable with 9 trials, with the heaviest enrollment activity in Plainfield, San Antonio, and Montreal. Lead sponsors running human papilloma virus studies include Universiteit Antwerpen, Verrica Pharmaceuticals Inc., and Centre hospitalier de l'Université de Montréal (CHUM).

Browse human papilloma virus trials by phase

Treatments under study

About Human Papilloma Virus Clinical Trials

Looking for clinical trials for Human Papilloma Virus? There are currently 21 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Human Papilloma Virus trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Human Papilloma Virus clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 33 trials

Recruiting

HPV Equity Study: Exploring Cervical Cancer Control in Scotland for Women With Experience of Priority Risks

Human Papilloma Virus
University of Edinburgh500 enrolled1 locationNCT06414057
Recruiting
Not Applicable

Unidos Contra el VPH

Cervical CancersHuman Papilloma Virus (HPV)
University of Texas at Austin735 enrolled1 locationNCT06825689
Recruiting
Phase 2

Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION)

Squamous Cell CarcinomaHuman Papilloma Virus (HPV)Oropharyngeal Squamous Cell Carcinoma (OPSCC)
Medical University of South Carolina36 enrolled1 locationNCT07513389
Recruiting
Not Applicable

The STOP-HPV Scale Up Study

Human Papilloma Virus Vaccine
University of California, Los Angeles100,000 enrolled1 locationNCT06831383
Recruiting
Phase 1

Intratumoral Lidocaine Injection Before Oropharyngeal Cancer Surgery

Oropharyngeal CancerSquamous Cell CarcinomaHuman Papilloma Virus+1 more
Ryan Carey30 enrolled1 locationNCT06747390
Recruiting
Phase 2

PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia

Cervical Intraepithelial Neoplasia Grade 2/3Human Papilloma Virus Infection Type 16
PapiVax Biotech, Inc.138 enrolled10 locationsNCT07454915
Recruiting
Phase 3

Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)

Human Papilloma Virus (HPV)WartsCommon Warts+1 more
Verrica Pharmaceuticals Inc.600 enrolled4 locationsNCT07457918
Recruiting
Not Applicable

Pre-Op MRI on Margin Status for Transoral Robotic Surgery for HPV+ Tonsillar Squamous Cell Carcinoma

Human Papilloma Virus Related CarcinomaTonsillar Squamous Cell Carcinoma
Case Comprehensive Cancer Center30 enrolled1 locationNCT07060261
Recruiting
Phase 2

A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer

Oropharyngeal CancerThroat CancerHuman Papilloma Virus+2 more
Memorial Sloan Kettering Cancer Center121 enrolled7 locationsNCT05491512
Recruiting
Early Phase 1

Merck IIT: RRP Pembro and Lenvatinib

Pulmonary DiseaseRecurrent Respiratory PapillomatosisHuman Papilloma Virus
Yale University20 enrolled1 locationNCT04645602
Recruiting

Multidimensional and Multimodal Profiling of Oropharyngeal Carcinoma

Human Papilloma VirusOropharyngeal Carcinoma
Stanford University1,000 enrolled1 locationNCT05880797
Recruiting
Phase 2

Developing a First-void Urine-based Infection Model to Study HPV-specific Antibody-virion Interaction Before and After HPV Vaccination

Human Papilloma Virus Infection Type 16
Universiteit Antwerpen50 enrolled3 locationsNCT07407569
Recruiting
Phase 1Phase 2

TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers

Head and Neck CancerHPV Positive Oropharyngeal Squamous Cell CarcinomaHuman Papilloma Virus+1 more
University of Chicago98 enrolled1 locationNCT05108870
Recruiting

Using Plasma Human Papillomavirus (HPV)-Related Deoxyribonucleic Acid (DNA) and Ribonucleic Acid (RNA) to Follow Response of Cervical Cancer to Surgery, Radiation, and Chemotherapy

Cervical CancerHuman Papilloma Virus (HPV)
University of Florida55 enrolled1 locationNCT07214584
Recruiting
Phase 4

A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV

Human Papilloma VirusHPVHuman Immunodeficiency Virus
University of British Columbia275 enrolled10 locationsNCT05495906
Recruiting
Phase 3

Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)

Human Papilloma Virus (HPV)WartsCommon Warts+1 more
Verrica Pharmaceuticals Inc.300 enrolled6 locationsNCT07246590
Recruiting

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

Streptococcus PneumoniaeMalariaMeningitis+55 more
Institut Pasteur du Cambodge10,000 enrolled1 locationNCT07358910
Recruiting
Not Applicable

PopSci CHW4CervixHealth

Cervical CancerHuman Papilloma VirusHPV Infection+1 more
Thomas Jefferson University120 enrolled1 locationNCT07336134
Recruiting
Not Applicable

Educate and Improve Underserved Populations' Uptake and Completion of the HPV Vaccine

Human Papilloma Virus
University of Colorado, Denver1,000 enrolled1 locationNCT04611022
Recruiting

Prevention of Cervical Cancer Using the Genotyping Screening and Same-day Self-sampling

Human Papilloma Virus
Atila Biosystems Inc.5,000 enrolled4 locationsNCT07232355